[Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001966:Bromine; D004906:Erythrocyte Count; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D010885:Pipobroman / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy*; D011422:Propionates; D013163:Splenomegaly / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced
D000970:Antineoplastic Agents; D010879:Piperazines; D011422:Propionates; D010885:Pipobroman; D001966:Bromine
Traitement de la polycythémie de Vaquez par le 1-4-bis (3 bromopropionyl-piperazine). Etude de 36 cas.